ArticleClujul medical (1957)2018

Intraperitoneal administration of rosuvastatin prevents postoperative peritoneal adhesions by decreasing the release of tumor necrosis factor.

Stefan Chiorescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.